NewCardio, Inc.
NWCI
$0.00
$0.000.00%
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | -90.02% | 381.52% | -20.20% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.02% | 381.52% | -20.20% | -- | -- |
| Cost of Revenue | -40.60% | -19.87% | 233.51% | -- | -- |
| Gross Profit | -133.27% | 376.79% | -173.86% | -- | -- |
| SG&A Expenses | -18.80% | -33.41% | -36.38% | -43.18% | -22.94% |
| Depreciation & Amortization | -2.48% | 3.48% | 17.14% | -79.03% | -32.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.29% | -32.97% | -28.75% | -22.94% | -15.32% |
| Operating Income | 17.68% | 36.19% | 28.90% | 26.07% | 19.54% |
| Income Before Tax | 8.99% | 36.22% | 44.04% | -135.90% | 23.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.99% | 36.22% | 44.04% | -135.90% | 23.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.99% | 36.22% | 44.04% | -135.90% | 23.68% |
| EBIT | 17.68% | 36.19% | 28.90% | 26.07% | 19.54% |
| EBITDA | 17.87% | 36.47% | 29.16% | 26.32% | 19.79% |
| EPS Basic | 17.45% | 43.69% | 52.10% | -25.92% | 40.28% |
| Normalized Basic EPS | 17.55% | 81.77% | 63.60% | -88.29% | 34.89% |
| EPS Diluted | 17.45% | 43.69% | 52.10% | -25.92% | 40.28% |
| Normalized Diluted EPS | 17.55% | 81.77% | 63.60% | -88.29% | 34.89% |
| Average Basic Shares Outstanding | 10.34% | 13.10% | 16.76% | 25.29% | 23.61% |
| Average Diluted Shares Outstanding | 10.34% | 13.10% | 16.76% | 25.29% | 23.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
